Mikael Sodergren Research Groups
This research focuses on the innovative application of eye tracking technology to improve outcomes in patients undergoing surgery and other medical interventions.
This group studies the techniques that modify the immune response to tumours, with particular emphasis on pancreatic ductal adenocarcinoma. We are particularly interested in therapies that can be leveraged in the peri-operative setting to improve outcomes.
This research programme evaluates and develops novel therapies targeting the endocannabinoid system through a framework of in vitro, in vivo and clinical translational activities.